Cargando…

Lower Intensified Target LDL-c Level of Statin Therapy Results in a Higher Risk of Incident Diabetes: A Meta-Analysis

BACKGROUND: A recent meta-analysis has reported that intensive-dose statin drug increases the risk of incident diabetes. However, doubling of the statin dose generates only a further 6% decrease in low-density lipoprotein cholesterol (LDL-c) on average. This study aimed to determine whether statin t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Rongrong, Yuan, Yang, Zhou, Yi, Xia, Wenqing, Wang, Pin, Sun, Haixia, Yang, Yue, Huang, Rong, Wang, Shaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133238/ https://www.ncbi.nlm.nih.gov/pubmed/25122464 http://dx.doi.org/10.1371/journal.pone.0104922

Ejemplares similares

Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis
por: Sun, Haixia, et al.
Publicado: (2015)

An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials
por: Sun, Jie, et al.
Publicado: (2015)

Should We Intensify Statin Management in ACS Patients with Very Low LDL Cholesterol Levels?
por: Han, Ki Hoon
Publicado: (2019)

RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study
por: Wang, Pin, et al.
Publicado: (2016)

Disrupted resting-state attentional networks in T2DM patients
por: Xia, Wenqing, et al.
Publicado: (2015)

Insulin Resistance-Associated Interhemispheric Functional Connectivity Alterations in T2DM: A Resting-State fMRI Study
por: Xia, Wenqing, et al.
Publicado: (2015)

Advanced Glycation End Product-Induced Astrocytic Differentiation of Cultured Neurospheres through Inhibition of Notch-Hes1 Pathway-Mediated Neurogenesis
por: Guo, Yijing, et al.
Publicado: (2013)

HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
por: Wang, Pin, et al.
Publicado: (2015)

Unmet Needs in LDL-C Lowering: When Statins Won’t Do!
por: Krähenbühl, Stephan, et al.
Publicado: (2016)

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation
por: Dadon, Ziv, et al.
Publicado: (2021)

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)

Targets of statins intervention in LDL-C metabolism: Gut microbiota
por: Sun, ChangXin, et al.
Publicado: (2022)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
por: Shanes, Jeffrey G.
Publicado: (2011)

Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes
por: Cai, Rongrong, et al.
Publicado: (2017)

Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta‐Analysis
por: Zhang, Xin‐Lin, et al.
Publicado: (2019)

Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis
por: Wang, Shaohua, et al.
Publicado: (2017)

Poorly controlled cholesterol is associated with cognitive impairment in T2DM: a resting-state fMRI study
por: Xia, Wenqing, et al.
Publicado: (2015)

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale
por: Inazawa, Takeshi, et al.
Publicado: (2013)

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins
por: Sakamoto, Kentaro, et al.
Publicado: (2015)

The Expected Cardiovascular Benefit of Plasma Cholesterol Lowering with or Without LDL-C Targets in Healthy Individuals at Higher Cardiovascular Risk
por: Cesena, Fernando Henpin Yue, et al.
Publicado: (2017)

Effectiveness and safety of combinational therapy compared with intensified statin monotherapy in patients with coronary heart disease
por: Liu, Chenghua, et al.
Publicado: (2018)

Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
por: Kim, Kyungpil, et al.
Publicado: (2014)

Evaluation of LDL goal achievement in statin consumption, south east of Iran
por: Aghasizadeh, Malihe, et al.
Publicado: (2021)

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
por: Clem, James R, et al.
Publicado: (2009)

Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C
por: Katzmann, Julius L., et al.
Publicado: (2020)

Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Negative frequency-dependent selection is intensified at higher population densities in protist populations
por: Minter, Ewan J. A., et al.
Publicado: (2015)

COVID-19 and crises of higher education: Responses and intensifying inequalities in the Global South
por: Husain, Matt M
Publicado: (2021)

LDL receptor knock-out mice show impaired spatial cognition with hippocampal vulnerability to apoptosis and deficits in synapses
por: Wang, Shao-hua, et al.
Publicado: (2014)

Saitohin Q7R polymorphism is associated with late‐onset Alzheimer's disease susceptibility among caucasian populations: a meta‐analysis
por: Huang, Rong, et al.
Publicado: (2017)

Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease
por: Steffens, Daniel, et al.
Publicado: (2021)

Higher dose statins after stroke
Publicado: (2021)

Blood Pressure is Associated With Cerebral Blood Flow Alterations in Patients With T2DM as Revealed by Perfusion Functional MRI
por: Xia, Wenqing, et al.
Publicado: (2015)

Higher prevalence of elevated LDL-C than non-HDL-C and low statin treatment rate in elderly community-dwelling Chinese with high cardiovascular risk
por: Kuang, YaShu, et al.
Publicado: (2016)

Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents
por: Konrad, Robert J, et al.
Publicado: (2011)

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
por: Postmus, Iris, et al.
Publicado: (2014)

Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid‐Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease
por: Le, Ngoc‐Anh, et al.
Publicado: (2015)

Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Publicado: (2012)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
por: Cholesterol Treatment Trialists' (CTT) Collaborators
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eapsoj9a7lbj6hi6kq0reeg4l8